Pharmacokinetic Study of Antiretroviral Drugs and Related Drugs During and After Pregnancy

Very Early Intensive Treatment of HIV-Infected Infants to Achieve HIV Remission

Evaluating the Pharmacokinetics, Safety, and Tolerability of Doravirine (MK-1439) and Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (MK-1439A) in HIV-1-Infected Children and Adolescents

More Options for Children and Adolescents (MOCHA): Oral and Long-Acting Injectable Cabotegravir and Rilpivirine in HIV-Infected Children and Adolescents

Safety of and Immune Response to Dolutegravir in HIV-1 Infected Infants, Children, and Adolescents

Safety, Tolerability, Drug Interactions, and Antiviral Activity of Rilpivirine in Antiretroviral-Naive HIV-Infected Children Less Than 12 Years of Age